Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

n. It is designed to instruct the patient’s immune system to produce an antibody response against angiotensin II. Angiotensin II is a small peptide in the body and part of the so-called renin-angiotensin system (RAS), an important regulator of blood pressure. Angiotensin II causes blood vessels to narrow,
resulting in increased blood pressure. In a phase IIa clinical trial, vaccination with CYT006-AngQb has been shown to reduce blood pressure by induction of antibodies that bind angiotensin II. Thereby, binding of angiotensin II to its receptors and subsequent narrowing of blood vessels should be decreased. The RAS has already been successfully targeted by three major classes of antihypertensive drugs on the market: inhibitors of the angiotensin-converting-enzyme (ACE), antagonists of the angiotensin II type I receptor (ARBs) and renin inhibitors. Like other antihypertensive drugs these also come with the need for daily dosing and fail to provide a solution for improving patient compliance. Treatment with CYT006-AngQb should allow for convenient dosing schedules and smooth control of blood pressure due to a sustained antibody response induced by vaccination.



About Cytos Biotechnology AG
Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the ImmunodrugsTM. ImmunodrugsTM are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. ImmunodrugsTM are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. Taking advantage of the high flexibility of its ImmunodrugTM platform, Cytos Biotechnology has built a pipeline of different ImmunodrugTM candidates in various disease areas, of which 6 are currently in clinical development. The Imm
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:7/28/2015)... July 28, 2015   Cynosure, Inc. ... markets medical devices for aesthetic procedures and precision ... the three months ended June 30, 2015. ... of double-digit growth, as revenues increased 47 percent ... Chief Executive Officer Michael Davin. "While our international ...
(Date:7/28/2015)... DURHAM, N.C. , July 28, 2015 ... of equity financing totaling $13 million. The oversubscribed round ... LLC (managers of the Duke endowment), Cunning Capital, Triad, ... the North Carolina Biotechnology Center. Many of Advanced Liquid ... Baebies, executive team, also invested. "Rex ...
(Date:7/28/2015)... July 28, 2015  CryoLife, Inc. (NYSE: CRY ... focused on cardiac and vascular surgery, announced today its ... of 2015.  Pat Mackin, Chairman, President ... continued to execute on our growth strategy with solid ... June, we announced plans to transition to a direct ...
Breaking Medicine Technology:Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14
... prostatectomy and prostate cancer treatment expert Dr. David ... and Minimally Invasive Surgery at The Mount Sinai Medical Center in ... discuss the successes of robotic surgery in prostate cancer ... robotic surgery a preferential method for prostate cancer ...
... American Medical Systems® (AMS) (NASDAQ: AMMD), ... male and female pelvic health, today announced it has ... and Welfare (MHLW) to market and distribute its GreenLight ... Prostatic Hyperplasia (BPH), or enlarged prostate, in Japan. ...
Cached Medicine Technology:Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment 2Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment 3American Medical Systems' GreenLight HPS® Approved for Use in Japan 2
(Date:7/28/2015)... ... July 28, 2015 , ... By 2016, the number ... ability to engage with customers on a highly personal basis, increasing customer loyalty. However, ... on big growth opportunities or lose customers to more nimble competitors. , The Open ...
(Date:7/28/2015)... ... July 28, 2015 , ... Representatives with CareMed Urgent ... full support of National Immunization Awareness Month, which is the month of August. ... serious illnesses like the flu, measles, and pneumonia, adults need to get their ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... intelligent gateways, and embedded building blocks for edge devices that enable the Internet ... with 4th generation Intel® Core™ i7/i5 processor to provide exceptional computing power and ...
(Date:7/28/2015)... ... , ... Master flutist and solo artist Gary Stroutsos shares his deep resume ... collection of serene, restorative instrumental music. Tracks carefully curated by White Swan producer ... and more -- to help the listener deeply breathe in a healing inner light ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... According to ... able to stop the cycle of addiction in lab mice. The study involving isradipine ... for the new prospect of helping their clients overcome drug and alcohol addictions. The ...
Breaking Medicine News(10 mins):Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 3Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 4Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3
... a child for a sore throat can often be prevented ... ,Children are prescribed antibiotics all too often when they ... administering a simple test for strep throat, says an eight-year ... ,As many as 53 percent of the estimated 7.3 million ...
... findings suggest that reflecting on personal values can keep ... ,Stress is implicated in the development //and progression ... disorders. ,Theory and research on the self suggest that ... ,A recent study, published in the November issue of ...
... from Henry Ford Health system had found that Black ... undergo lung cancer surgery at a comparatively higher rate ... blacks were misinformed about the effects of lung cancer ... rate of lung cancer surgery acceptance among blacks. ...
... is one of the main causes of tooth loss ... the tooth extractions (those with periodontal disease lost 2.8 ... disease). It has now been found out from research ... periodontal destruction than others. ,The study analyzed ...
... by many, because of its omega-3 fatty acids and, ... of farmed (mostly Atlantic salmon) and wild salmon fish// ... salmon, are contaminated with more environmental pollutants such as ... from Alaska. Many consumers have a choice between farm-raised ...
... conducted in Germany indicates that bronchiolo–alveolar carcinoma frequently shows a ... The acoustic–physical conditions ... sonographic diagnosis of pulmonary diseases. , ... of pleural-based lesions has been established as a method complementary ...
Cached Medicine News:Health News:Antibiotics Given Too Often For Sore Throat: Study 2Health News:Blacks decline Lung cancer surgery 2Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 2Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 3
... or 96 temperature cyclers, the gradient block can ... of up to 14 or 22 across the ... difference of up to 2C between adjacent wells ... up to 12 different annealing temperatures in a ...
... The Techne TC412 is a high performance, ... price. Features & Benefits include: Flexible ... intuituve programming, 8 peltiers, PC networking. Includes ... Up to 32 Techne cyclers can be connected ...
... is the smallest footprint two-bay thermal cycler ... before. The Disciple instrument is ... to a computer using a remote command ... cycler contains the latest in power electronics ...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
Medicine Products: